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Abstract
Zirconium (Zr) is an element commonly used in dental and orthopedic implants either as zir-
conia (ZrO2) or in metal alloys. It can also be incorporated into calcium silicate-based ce-
ramics. However, the effects of in vitro culture of human osteoblasts (HOBs) with soluble
ionic forms of Zr have not been determined. In this study, primary culture of human osteo-
blasts was conducted in the presence of medium containing either ZrCl4 or Zirconium (IV)
oxynitrate (ZrO(NO3)2) at concentrations of 0, 5, 50 and 500 µM, and osteoblast prolifera-
tion, differentiation and calcium deposition were assessed. Incubation of human osteoblast
cultures with Zr ions increased the proliferation of human osteoblasts and also gene expres-
sion of genetic markers of osteoblast differentiation. In 21 and 28 day cultures, Zr ions at
concentrations of 50 and 500 µM increased the deposition of calcium phosphate. In addi-
tion, the gene expression of BMP2 and BMP receptors was increased in response to culture
with Zr ions and this was associated with increased phosphorylation of SMAD1/5. More-
over, Noggin suppressed osteogenic gene expression in HOBs co-treated with Zr ions. In
conclusion, Zr ions appear able to induce both the proliferation and the differentiation of pri-
mary human osteoblasts. This is associated with up-regulation of BMP2 expression and ac-
tivation of BMP signaling suggesting this action is, at least in part, mediated by BMP
signaling.
Introduction
Zirconium (Zr) is one of the more common trace elements present in the environment [1]. It is
a metallic element with a valency of 4 that is normally present in human bone and tissues at a
trace level in the range 2–20 mg/kg body weight with an estimated average daily intake in hu-
mans of 3.5 mg [1]. Toxicity of Zr has been assessed as low to moderate in animals [1].
Zr containing materials, predominantly as the stable and biologically inert zirconium oxide
(ZrO2) and metal alloys, have been widely used in dental applications and as coatings for
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orthopaedic implants due to their contributions to biocompatibility, increased mechanical
strength, and high corrosion resistance [2–5].
Recently we have developed a calcium silicate-based ceramic, baghdadite (Ca3Zr[O2Si2O7])
(Patent Application # 792007905843) incorporating Zr which can be released as Zr ions into
aqueous media. This ceramic was more labile than the ZrO2 and has been shown to release Zr
into solutions simulating body fluids at concentrations in the range 10–100 µM [6]. This ce-
ramic when fabricated as a porous scaffold, has been shown to have excellent osteogenic bio-
activity in vitro and in vivo [6, 7] when compared to calcium silicate ceramics. This ceramic
material has been tested in a critical sized bone defect model in the rabbit and appears to be su-
perior in promoting osteogenesis than the currently used clinical implant materials containing
calcium triphosphate and hydroxyapatite [6]. We further demonstrated that Baghdadite scaf-
folds can modulate the crosstalk between adipose stem cells (ASCs) and primary human osteo-
blasts (HOBs) to promote osteogenic gene expression in both ASCs and HOBs in an indirect
co-culture system [8].
However the mechanism for this enhanced bioactivity has not been identified, and, in par-
ticular, the in vitro effects of Zr ions on human osteoblasts have not previously been studied.
Review of the literature indicates an absence of studies evaluating the effects of Zr ions in cells
of the osteoblast lineage. There has been one limited study reported in the literature examining
the in vitro toxicity of Zr on the osteoblast-like cell line MG63 which showed cell toxicity in the
millimolar concentration range but which did not investigate the effects of Zr ions on the pro-
liferation and differentiation of these cells at lower more clinically relevant concentrations [9].
The response of osteoblast-like cell lines and human osteoblasts have been assessed when
grown on Zr containing alloys and ceramics [7, 10–18] but in none of these is it possible to dif-
ferentiate surface morphology effects and the influence of other material components from
those of Zr itself.
Various trace elements have been found to have activity on bone cells. Strontium [19] and
fluoride ions [20] have each been shown to have osteogenic properties for in vitro osteoblast
cell cultures and when administered systemically, and gallium has been found to inhibit the ac-
tivity of osteoclasts and inhibit bone resorption [21]. Zr ions have not been assessed for osteo-
genic properties and it is thus possible that the benefits of incorporating Zr in implanted
materials could include local direct effects on bone formation. Two forms of Zr that are readily
soluble in aqueous solutions are Zirconium (IV) oxynitrate (ZrO(NO3)2) and zirconium chlo-
ride (ZrCl4) and these are used in the present study to generate culture media containing Zr
ions. The determination of the actual ionic species in aqueous solutions is complex as simple
Zr4+ ions are absent in aqueous solutions where extensive hydrolysis leads to the formation of
oligomeric species such as Zr4(OH)4
8+(aq) [22] but for the purposes of this current study, fur-
ther characterization of the actual ionic species present will not be addressed.
In this study we show that Zr ions do have the ability to promote the proliferation and dif-
ferentiation of human osteoblasts in vitro and that this effect is associated with, and may be
mediated by, up-regulation of BMP2 expression and increased BMP signaling.
Materials and Methods
Isolation and culture of primary HOBs
The use of primary human osteoblasts isolated from unneeded surgically removed bone was
approved by the Human Ethics Committee of the University of Sydney. As the source of the
bone was from minors, written informed consent was obtained from parents/guardians of the
subjects. Both the protocol and the consent procedures were approved by the Human Ethics
Committee of the University of Sydney. HOBs were isolated previously described [23] from
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discarded human vertebral trabecular bone from young (<15 years) healthy adolescents under-
going operations correcting scoliosis. Briefly, bone was cut into 1 mm3 pieces and washed with
phosphate-buffered saline (PBS). Bone pieces were digested in 0.02% trypsin (Sigma-Aldrich)
for 90 minutes at 37°C. The digested cells were cultured in complete α-minimal essential medi-
um (αMEM, Gibco Laboratories) supplemented with 10% (v/v) heat-inactivated fetal calf
serum (FCS, Gibco Laboratories), 100 units/ml penicillin and streptomycin (Gibco Laborato-
ries) and 1 mM L-ascorbic acid phosphate magnesium salt (Wako Pure Chemicals) at 37°C
with 5% CO2 in a humidity atmosphere. Only Passage 2 or 3 HOB cells were used in this study.
Chemicals and HOB treatments
ZrO(NO3)2, ZrCl4 and sodium nitrate (NaNO3) were purchased from Sigma-Aldrich. Zr com-
pound solutions were made by dissolving the chemical powders in PBS (pH 7.4) and sterilized
by filtration through 0.2 µm pore syringe filters (Millipore). The solutions of ZrO(NO3)2 and
ZrCl4 were stored at 4°C as stocks at concentrations of 5, 50 and 500 mM respectively. For use
in treatment of HOB cell cultures, the stock solutions were diluted to final concentrations of Zr
in the medium of 5, 50 and 500 µM. HOBs were incubated in the complete medium with addi-
tion of an appropriate volume of PBS alone for untreated control conditions (refer as “Control”
in the text and figures below). An additional control containing 50 µM concentration of
NaNO3 in PBS was used in these studies to determine whether the NO3- ions in the ZrO
(NO3)2 containing culture media may have impacted HOB osteogenesis. The medium with the
treatments was refreshed every 3 days.
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay
HOB cells at Passage 3 were seeded in 96-well plates, 1x104 cells/well. Cells were incubated in
the complete αMEM containing Zr chemicals ZrO(NO3)2 and ZrCl4 at different concentra-
tions with an untreated control and a NaNO3-treated control for 1, 3 and 7 days. In each treat-
ment group, a MTT (Sigma-Aldrich) assay was used to evaluate the number of viable cells
present. HOBs were incubated with 2.5 mg/ml MTT for 2 hours at 37°C. The MTT solution
was then removed and replaced with 100 µl DMSO to solubilize the formazan dye formed.
After the plate was shaken on the shaker for 10 minutes, the absorbance of each well was read
at 570 nm in a microplate photometer (Thermo Multiscan EX).
Mineralized matrix formation
HOBs were seeded in 24-well plates at the density of 5x104 cells/well and cultured in the com-
plete αMEMmedium. Cells were treated with Zr chemicals, complete medium as an untreated
control, or a solution containing NaNO3 for 21 and 28 days. Medium with the treatment was
refreshed every 3 days. Alizarin Red S Staining was carried out as previously described [24]. In
brief, at each time point, cells were washed with Millipore water and incubated in Alizarin Red
S Solution (pH 4.3) for 30 minutes at room temperature. Then cells were washed in water for
four times and stored in water for image acquisition using a bright field light microscope
(Olympus).
Quantitative real time polymerase chain reaction
Total RNA extraction was carried out as previously described [25]. Briefly, HOBs were treated
with and without Zr chemicals; or HOBs were co-incubated with Noggin (500 ng/ml, Sigma-
Aldrich) and ZrCl4 at the concentrations of 50 and 500 µM, for 3 and 7 days. The medium was
removed and cells were washed with ice-cold PBS. Trizol Reagent (Sigma-Aldrich) was added
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into each well. The following steps were performed after precipitation of the RNA in isopropa-
nol and washing of the RNA pellets in 70% ethanol. RNA was dissolved in DEPC-H2O and the
concentration of RNA was quantified on a NanoDrop spectrophotometer (Thermo Fisher).
First-strand cDNA was synthesized from 1µg of RNA using a Tero cDNA synthesis kit (Bio-
line) according to the manufacturer’s instructions. Osteogenic genes, including osteopontin
(OPN), bone sialoprotein (BSP), runt-related transcription factor 2 (Runx2), osteocalcin (OC),
alkaline phosphatase (ALP), bone morphogenetic protein 2 (BMP2), BMP receptor 1a
(BMPR1a), BMPR1b and BMPR2 were analyzed using a Rotor-gene 6000 (Corbett Life Sci-
ence). Relative gene expression was normalized with the house-keeping gene 18S. Primers for
the genes are listed in Table 1.
Protein extraction andWestern Blot analysis
HOB cells were seeded on 6-well plates at a density of 5x104 cells/well and cultured with Zr so-
lutions at the final concentrations of 5, 50 and 500 µM for 7 days. Untreated controls and
NaNO3-treated controls were used. At D7, cells were washed with ice-cold PBS and lysed in
Radio Immuno Precipitation Assay (RIPA) lysis buffer containing 20 mM Tris-HCl (pH 7.5),
1 mM ethylenediaminetetraacetic acid, 1 mM ethylene glycol tetraacetic acid (EGTA), 150 mM
NaCl, 1% Triton X-100, 1% protein inhibitor cocktail solution (PICS, Sigma-Aldrich) and
phosphatase inhibitor (Roche). Protein concentrations were measured using the bicinchoninic
acid (BCA) assay kit (Pierce). 10 µg protein samples in 4x sample buffer (WesternBreeze, Invi-
trogen) were heated at 70°C for 10 minutes and separated on 8%–12% sodium dodecylsulphate
(SDS)-polyacrylamide electrophoresis gels (WesternBreeze, Invitrogen). Proteins were
Table 1. Primers Used for Real-Time Polymerase Chain Reaction.
Gene Sequence (5’–3’) Melting Temperature (°C)
18S F GTAACCCGTTGAACCCCATT 60
R CCATCCAATCGGTAGTAGCG
Osteopontin F TTCCAAGTAAGTCCAACGAAAG 60
R GTGACCAGTTCATCAGATTCAT
BSP F ATGGCCTGTGCTTTCTCAATG 60
R GGATAAAAGTAGGCATGCTTG
Runx2 F ATGCTTCATTCGCCTCAC 60
R ACTGCTTGCAGCCTTAAAT
Osteocalcin F ATGAGAGCCCTCACACTCCTCG 60
R GTCAGCCAACTCGTCACAGTCC
ALP F CGTGGCTAAGAATGTCATCATGTT 60
R AGGGGAACTTGTCCATCTCC
BMP2 F AGTTGCGGCTGCTCAGCATGTT 60
R CCGGGTTGTTTTCCCACT
BMPR1a F TTTATGGCACCCAAGGAAAG 60
R TGGTATTCAAGGGCACATCA
BMPR1b F AAAGGTCGCTATGGGGAAGT 60
R GCAGCAATGAAACCCAAAAT
BMPR2 F CATCCGAACCCTCTCTTGAT 60
R TGCATAAAGATCCATTGGGA
BSP, bone sialoprotein; Runx2, runt-related transcription factor 2; ALP, alkaline phosphatase; BMP2, bone morphogenetic protein 2; BMPR, BMP
receptor
doi:10.1371/journal.pone.0113426.t001
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transferred to the polyvinylidene fluoride (PVDF) membrane and washed with TBS-T (20 mM
Tris-HCl, pH 7.6 and 137 mMNaCl) containing 0.1% Tween 20. After blocking in TBS-T with
1% bovine serum albumin (BSA) for one hour at room temperature, the membrane was incu-
bated with the primary antibodies, anti-BMP2 (Abcam, 1:1000), anti-SMAD1(Cell signaling,
1:1000) or anti-phospho-SMAD1/5 (p-SMAD1/5, Cell signaling, 1:500) in blocking buffer on
the shaker at 4°C overnight. Following three washes, the membrane was incubated in the sec-
ondary antibody conjugated with Alkaline Phosphatase (AP) (WesternBreeze, Invitrogen) for
one hour at room temperature. Chemilluminescent reagent (WesternBreeze, Invitrogen) was
used to observe the protein bands under the Bio-Rad ChemiDoc MP Imaging System (Bio-
Rad). For β-actin detection, the same membrane was stripped in the stripping buffer contain-
ing 60 mM Tris-HCl (pH6.8), 7% β-mercaptoethanol and 2% SDS at 50°C for 30 minutes
under gentle agitation. The membrane was then incubated with anti-β-actin antibody (Abcam,
1:5000) for the loading control after blocking in the blocking buffer for one hour.
Immunocytochemistry
HOBs were seeded on the coverslips and incubated with Zr solutions at 5, 50 and 500 µM, or
NaNO3 solution at 50 µM or complete medium for 7 days. After washing in PBS for three
times, cells were fixed in 4% paraformaldehyde for 20 minutes. Immunostaining of the treated
HOBs was carried out using anti-Ki67 (1:100, Abcam), anti-BMP2 (1:500, Abcam), anti-p-
SMAD1/5 (1:100, Cell Signaling) primary antibodies to detect protein activation through phos-
phorylation. The antibody, anti-p-SMAD1/5 (S463/S465), used recognizes phosphorylated
forms of both SMAD1 and SMAD5 when phosphorylated at Ser463 and Ser465. The incuba-
tion with the primary antibody was processed in a humidity chamber overnight at 4°C. Ki67 re-
activity was visualized with the secondary antibody anti-rabbit conjugated with horse radish
peroxidase (HRP, Abcam) and 3,3’-diaminobenzidine (DAB) substrate. Hematoxylin was used
for the nuclear counterstaining. The images were acquired under the bright field light micro-
scope (Olympus). The immunofluorescence staining of BMP2 and p-SMAD1/5 was analyzed
by incubating with the secondary antibody of anti-rabbit conjugated with Alexa-488 (Abcam)
and then with DAPI for nucleus staining. The immunofluorescence was visualized under the
fluorescent microscope (Olympus).
Statistical analysis
Data from this study were obtained from three independent experiments and are represented
as mean ± SD. Statistical analysis of data was performed by One-way ANOVA and Dunnett’s
Post Hoc Test using a SPSS statistical software package (IBM Version 21).
Results
Zr ions increase HOB cell proliferation
The effects of Zr treatments on the number of viable HOBs were examined using a MTT assay.
HOBs at Passage 3 were treated with ZrO(NO3)2 or ZrCl4 solutions at the final concentrations
in the medium of 5, 50 and 500 µM and incubated for 1, 3 and 7 days, while the complete medi-
um or NaNO3 solution at 50 µM in medium was used as an untreated control and a control for
the nitrate content of ZrO(NO3)2. Compared to the untreated control and the NaNO3 control,
at D1, D3 and D7, ZrO(NO3)2 and ZrCl4 at all concentrations greater than 5 µM significantly
stimulated HOB proliferation. At D3 this increase was also significant for ZrO(NO3)2 at 5 µM
(Fig. 1A). At D3 and D7 viable cell number increased progressively in each treatment and
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control group (p<0.01). There was no difference in the absorbance between the control group
and NaNO3-50 µM group at D1, D3 and D7.
To further investigate the effects of Zr on HOB proliferation, immunostaining was carried
out to assess the cell proliferation marker Ki67 labeling in HOBs. Increased Ki67 staining was
observed in the nucleus in HOBs in Zr treatment groups (Fig. 1D-F, H-J) relative to the control
groups (Fig. 1C,G). The quantification of Ki67-positive cells in total cells showed that, com-
pared to the controls, Ki67-positive cells in ZrO(NO3)2 and ZrCl4-treated HOBs at D7 were
significantly increased in all treatment groups (Fig. 1B), by 20–50%. There was no difference
that was observed between the treatment groups at different concentrations. The Ki67 results
confirm that the increase in viable cell number detected by MTT results, at least in part, from
increased HOB cell proliferation.
Zr ions induce mineralization in HOB cultures
The induction of matrix mineralization in HOB cultures is consistent with the progress of dif-
ferentiation to the formation of mature osteoblasts capable of bone matrix formation. To evalu-
ate Zr ion effects in the HOB maturation, HOBs were incubated with Zr solutions and control
Figure 1. Zirconium ion promotes HOB proliferation. (A) The MTT assay was used to determine the HOB viability after HOBs were treated with zirconium
solutions with different concentrations for 1, 3 and 7 days. Compared to the control and NaNO3-treated control, higher concentrations of zirconium
significantly increased HOB viability. ZrO(NO3)2 at 5µM increased cell proliferation at D1 and D3 but not D7, whereas ZrCl4 at 5µM had no effects on HOB
proliferation. However, higher concentrations of both of zirconium solutions significantly increased cell proliferation at D1, D3 and D7. Between the time
points, viable cell number in each treatment group are significantly increased (p<0.01). (B) The graph shows the quantification of Ki67 positive cells to total
cells. Compared to the control, the proportion of Ki67-positive cells is significantly increased in all treatment groups. There were no significant differences
observed between the treatment groups at the different concentrations. (C-J) Representative images from each treatment group following KI67
immunostaining. Arrows indicate the positive staining of cells with the Ki67 antibody (C). Scale bar: 100 µm. Data are Mean±SD of three separate
experiments. * p<0.05, **p<0.01 versus control.
doi:10.1371/journal.pone.0113426.g001
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media for 21 and 28 days with the medium changes every 3–4 days. Alizarin Red S Staining
was used to analyze mineralized matrix formation in the treated HOB cultures. As shown in
Fig. 2, the bone nodule formation in the HOB cells treated with Zr solutions was increased in a
dose-dependent manner with effects seen at both Day 21 and Day 28. At Day 21 and Day 28,
there were small patches of cells that were weakly stained with Alizarin Red (asterisks, Fig. 1A)
appearing in the untreated control and NaNO3-treated control. Compared to the controls, the
bone nodules formed in HOBs treated with ZrO(NO3)2 and ZrCl4 at 50 µM exhibited stronger
staining (arrows, Fig. 1 E,F,M,N). The staining of HOBs were observed to be much stronger in
the whole cell area and were greatest at the concentration of 500 µM (Fig. 1G,H,O,P) indicating
Zr ions stimulated matrix mineralization by HOBs.
Zr ions up-regulate osteoblast genetic markers and BMP2 gene
expression in HOBs
As Zr was shown to increase HOB cell proliferation and matrix mineralization, we next ana-
lyzed specific genes associated with osteoblast differentiation in the Zr-treated HOB cells to
Figure 2. Effects of zirconium ion onmineralization of HOBs at D21 and D28. (A, B) In the controls, patchy weak Alizarin Red S staining (asterisks, A)
was observed in HOBs at Day21 and D28. (C-H) ZrO(NO3)2 and (K-P) ZrCl4 dramatically promoted the formation of mineralized matrix (arrows, C, E),
compared to the control (A, B) and NaNO3-treated control (I and J). Scale bar: 100 µm.
doi:10.1371/journal.pone.0113426.g002
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validate the induction by Zr of differentiation into the osteoblast lineage. Total RNA was ex-
tracted from HOBs cultured in different Zr solutions or control media for 3 and 7 days, and
real-time PCR was carried out to evaluate the expression of the osteoblast marker genes OPN,
BSP, Runx2 and OC.
At D7, OPN gene expression was significantly up-regulated in HOBs treated with ZrO
(NO3)2 at the three different concentrations of 5, 50 and 500 µM (Fig. 3A), compared to the
controls. At D3, only ZrO(NO3)2 at 500 µM increased OPN expression. Similarly, ZrCl4 at 50
and 500 µM increased OPN expression at D3 and D7, but not 5 µM. Compared to the controls,
ZrO(NO3)2 at 50 and 500 µM up-regulated BSP expression at D7, but not at D3; whereas ZrCl4
at 50 µM and 500 µM increased BSP expression at D3 and D7 (Fig. 3B). Runx2 gene expression
was significantly increased by ZrO(NO3)2 and ZrCl4 at 5 and 50 µM at D3 (Fig. 3C). At D7,
ZrO(NO3)2 at all three different concentrations increased Runx2 expression. However, ZrCl4
increased Runx2 expression only at 50 and 500 µM. OC was evaluated by real time PCR as a
gene marker for later osteogenesis. ZrO(NO3)2 and ZrCl4 at 500 µM .increased OC expression
at D7 but not at D3. At D3, OC expression was up-regulated by ZrCl4 at 50 µM; however it was
suppressed by ZrO(NO3)2 at 5 and 500 µM and ZrCl4 at 5 µM (Fig. 3D). ALP expression was
up-regulated by ZrCl4 at 50 µM at D3 but no consistent evidence of regulation of ALP gene ex-
pression was seen (Fig. 3E).
Overall, ZrO(NO3)2 and ZrCl4 strongly increased osteogenic gene expression in the HOBs
cultured for 3 and/or 7 days. The upregulation of osteogenic genes indicates that Zr induces os-
teogenesis in primary HOBs.
To further investigate the mechanism of Zr-induced early osteogenesis, BMP2 genes and
BMP receptor genes were analyzed in HOBs cultured under different treatments with Zr solu-
tions and control media.
At D3 and D7, BMP2 gene expression was significantly up-regulated in HOBs treated with
ZrO(NO3)2 at 500 µM and ZrCl4 at 50 µM and 500 µM, compared to the control (Fig. 4A). For
BMPR gene expression at D3, BMPR1a expression was up-regulated compared to the control
in HOBs by ZrO(NO3)2 and ZrCl4 only at 500 µM. In HOBs treated for 7 days ZrO(NO3)2 and
ZrCl4 at 50 and 500 µM significantly increased BMPR1a expression (Fig. 4B). BMPR1a gene
expression seemed being inhibited by ZrCl4 at 5 µM at D3. BMPR1b expression was signifi-
cantly increased in HOBs treated with ZrO(NO3)2 and ZrCl4 at 50 and 500 µM at D3 and D7.
Increased BMPR1b expression was exhibited by ZrO(NO3)2 at 5 µM only at D7 whereas ZrCl4
at 5 µM only at D3, respectively, compared with the control (Fig. 4C). Zirconium solutions had
no effect on the BMPR2 expression in HOBs (Fig. 4D).
Generally, higher concentrations of ZrO(NO3)2 and ZrCl4 (500 µM) significantly increased
the expression of BMP2 and BMP receptor genes BMPR1a and BMPR1b at D3 and D7
(Fig. 4A-C).
Zr ions activate the BMP/SMAD1/5 signaling pathway
BMP/SMAD signaling pathways play critical roles in the regulation of osteoblast differentia-
tion. BMPs exert their functions through binding to Ser/Thr kinase receptors in the membrane
and subsequently phosphorylating the downstream effectors SMAD1 and SMAD5 at the
Ser463 and S465 sites. Phosphorylated SMAD1/5 is then translocated into the nucleus to acti-
vate the target gene transcription.
As the BMP2 and its receptor gene expression was up-regulated by Zr chemicals, we further
investigated the expression of BMP2 protein levels and its downstream effectors of SMAD1
and p-SMAD1/5. Western blotting was employed to evaluate the protein levels of BMP2,
SMAD1 and p-SMAD1/5 in HOBs cultured with different Zr solutions and control media for
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7 days (Fig. 5A). After normalizing the protein levels to those of β-actin, BMP2 protein found
to be increased 20% in HOBs after treatment with ZrO(NO3)2 at 500 µM and from 40% to 60%
with ZrCl4 treatment at 5 and 50 µM (Fig. 5B). The results showed that Zr ions significantly ac-
tivated the protein levels of SMAD1 as well as p-SMAD1/5 in HOBs (Fig. 5C, D). Furthermore,
the dose-response effects with steady increase of p-SMAD1/5 protein in Zr-treated HOBs
Figure 3. Zirconium ions up-regulate osteoblast genes in HOBs.Real-time PCR was used to analyze the
expression of osteoblast genes in zirconium-treated HOBs. (A) At D7, OPN gene expression was significantly
up-regulated in HOBs treated with ZrO(NO3)2 at concentrations of 5, 50 and 500 µM, compared to the
controls. At D3, only ZrO(NO3)2 at 500 µM increased OPN expression. ZrCl4 at 50 and 500 µM increased
OPN expression at D3 and D7, but not 5 µM. (B) Compared to the controls, ZrO(NO3)2 at 50 and 500 µM up-
regulated BSP expression at D7, but not at D3; whereas ZrCl4 at 50 µM and 500 µM increased BSP
expression at D3 and D7. (C) At D3, ZrO(NO3)2 and ZrCl4 at 5 and 50 µM increased Runx2 expression. At
D7, at all three different concentrations, ZrO(NO3)2 increased Runx2 expression; However, ZrCl4 increased
Runx2 expression only at 50 and 500 µM. (D) ZrO(NO3)2 and ZrCl4 at 500 µM increased OC expression at
D7. At D3, OC expression was up-regulated by ZrCl4 at 50 µM; However it was suppressed by ZrO(NO3)2 at
5 and 500 µM and ZrCl4 at 5 µM. (E) ALP expression was up-regulated by ZrCl4 at 50 µM at D3 but no
consistent evidence of regulation of ALP gene expression was seen. OPN, osteopontin; BSP, bone
sialoprotein; OC, osteocalcin; ALP, alkaline phosphatase. *p<0.05, **p<0.01 vs control.
doi:10.1371/journal.pone.0113426.g003
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cultured with low to high concentrations is consistent with the activation of SMAD1/5 signal-
ing pathway.
To confirm the activation of BMP2 and p-SMAD1/5 protein in HOBs by Zr ions, immuno-
staining was carried out to detect the protein localization in cells. HOBs were treated with Zr
solutions and control media at different concentrations for 7 days, and then were incubated
with anti-BMP2 or anti-p-SMAD1/5 antibodies for immunofluorescence. BMP2 was localized
strongly in the HOB nuclei and weakly in the cytoplasm in untreated control (arrows, Fig. 6A,
A’) and NaNO3 control (Fig. 6E,E’). In Zr-treated HOBs, BMP2 reactivity was significantly ele-
vated (Fig. 6B-D, F-H) compared with the controls. BMP2 accumulation was strongly observed
in the nuclei and cytoplasm in the Zr treatment groups at 50 and 500 µM (Fig. 6C,D,G,H).
p-SMAD1/5 was localized in the HOB nuclei and not cytoplasm in controls (arrows, Fig. 7A, E).
However, in HOBs treated with Zr solutions, p-SMAD1/5 was observed to appear strongly in
the nuclei and weakly in the cytoplasm (Fig. 7C,D,G,H). These results indicate that Zr ions sig-
nificantly stimulate BMP2 protein expression and subsequently stimulate SMAD1/5 phosphor-
ylation and pathway activation.
Figure 4. Zirconium ions up-regulate gene expression of BMP2 and BMPR in HOBs. HOBs were treated with ZrO(NO3)2 and ZrCl4 solutions at the
concentrations of 5, 50 and 500 µM for 3 and 7 days. Real-time PCR was employed to analyze the gene expression of BMP2 (A), BMP receptors BMPR1a
(B), BMPR1b (C) and BMPR2 (D). (A) At D3 and D7, BMP2 gene expression was significantly up-regulated in HOBs treated with ZrO(NO3)2 at 500 µM and
ZrCl4 at 50 µM and 500 µM, compared to the control. (B) At D3, BMPR1a expression was up-regulated in HOBs by ZrO(NO3)2 and ZrCl4 only at 500 µM,
compared to the control. ZrO(NO3)2 and ZrCl4 at 50 and 500 µM significantly increased BMPR1a expression in HOBs treated for 7 days. BMPR1a gene
expression was inhibited by ZrCl4 at 5 µM at D3. (C) BMPR1b expression was significantly increased in HOBs treated with ZrO(NO3)2 and ZrCl4 at 50 and
500 µM at D3 and D7. Increased BMPR1b expression was exhibited by ZrO(NO3)2 at 5 µM only at D7 whereas ZrCl4 at 5 µM only at D3, respectively,
compared with the control. (D) Zirconium solutions had no effect on the BMPR2 expression in HOBs.*p<0.05, **p<0.01 vs control.
doi:10.1371/journal.pone.0113426.g004
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Noggin suppressed osteogenic gene expression in HOBs co-incubated
with ZrCl4
In this study we have shown that Zr ion up-regulated the gene expression of BMP2 and BMP
receptor genes as well as promoted the proteins levels of BMP2 and the downstream effectors
SMAD1 and pSMAD1/5 in BMP signaling pathway. To investigate whether the osteogenic ef-
fects of Zr ions were mediated by activation of the BMP signaling pathway, Noggin, an inhibi-
tor of BMP signaling pathway, was added to HOB cultures in the presence of ZrCl4 at the
concentrations of 50 and 500 µM for 3 and 7 days. Real time PCR results showed that the oste-
ogenic genes OPN, BSP, Runx2 and OC, were upregulated in HOBs by ZrCl4 at concentrations
of 50 and 500 µM at D3 and D7 (Fig. 8). These results were consistent with the results shown
above (Fig. 3). Addition of Noggin to these cultures significantly suppressed the increase in
gene expression of OPN, BSP, Runx2 and OC at day 7 at a 500 µM ZrCl4 concentration. Nog-
gin also significantly reduced expression of RUNX2 and OPN at D3 at this concentration.
These results provide additional evidence the the effects of Zr ions on osteogenesic differentia-
tion of HOBs is dependent on BMP2 signaling.
Figure 5. Zirconium ions elevate protein levels in the BMP/SMAD signaling pathway. (A) Western blotting was used to determine the expression levels
of BMP2, SMAD1 and phospho-SMAD1/5 (p-SMAD1/5) in primary HOBs treated with ZrO(NO3)2 and ZrCl4 for 7 days. β-actin was used as the loading
control. (B) Quantification of Bmp2 protein bands indicated ZrO(NO3)2 at 500 µM increased Bmp2 protein level compared to the untreated and NaNO3
controls. Compared to the controls, ZrCl4 treatment increased BMP2 at the concentrations of 5 and 50 µM, but not at 500 µM. (C) Treatment of HOBs with
ZrO(NO3)2 at 50 and 500 µM increased SMAD1 protein expression, but SMAD1 levels were reduced at 5 µM, compared to the controls. ZrCl4 treatment
increased SMAD1 protein level at 5 and 50 µM but not 500 µM. (D) Both ZrO(NO3)2 and ZrCl4 treatment significantly and dose dependently increased the
p-SMAD1/5 levels in HOBs. *p<0.05, **p<0.01 vs control.
doi:10.1371/journal.pone.0113426.g005
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Discussion
This study identifies that Zr ions have a novel osteogenic activity on primary human osteo-
blasts. Zr ions were found to both increase the proliferation of human osteoblast precursors
and to enhance their differentiation into osteoblasts. These HOBs were derived from discarded
human bone fragments removed at surgery to correct scoliosis and come from young healthy
individuals without systemic illnesses. The primary cultures of these cells initially represent a
population of committed osteoblast precursors Early in culture they actively proliferate but
later proliferation slows and the processes of differentiation predominate [25–29]. In the pres-
ent study, we have identified the ability of Zr ions to increase the proliferation of HOBs at early
stages of culture. Growth in cell number was associated with increased cell expression of the
cell proliferation marker Ki67 indicating increased cell mitosis, rather than reduction in apo-
ptosis, mediated the increase in viable cell number.
Later in culture (day 21), and under minimal osteogenic conditions (culture with ascorbic
acid), HOBs have the ability to mature into osteoblasts and are then able to lay down collagen
matrix and stimulate its mineralization. During this differentiation process, various changes in
Figure 6. Localization of BMP2 in HOBs treated with zirconium solutions. In untreated control (A, A’) and NaNO3-reated control (E,E’)HOBs, BMP2
localized strongly in the cell nuclei (arrows) but weakly detected in the cytoplasm. In ZrO(NO3)2-treated HOBs (B-D), BMP2 is strongly localized in nuclei.
Localization of BMP2 protein is also strongly observed in the cytoplasm of HOBs treated with ZrO(NO3)2 at 50 and 500 µM (arrows, C,C’,D,D’). Localization
of BMP2 in ZrCl4-treated HOBs (F-H) is similar to that in ZrO(NO3)2-treated HOBs. Scale bar: 50 µm.
doi:10.1371/journal.pone.0113426.g006
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gene expression occur under the influence of autocrine signaling mediated by growth factors
such as BMP’s and Wnt’s. We have demonstrated that Zr ions are able to promote the later dif-
ferentiation of HOBs and enable them to lay down and mineralize bone matrix. Treatment
with Zr ions increased the amount of mineralized matrix deposited after 21 and 28 days of
HOB culture under osteogenic conditions. This increase in mineralization was preceded at
early stages of culture by increased expression of genes characteristic of osteoblasts. OPN and
BSP were increased at day three. Osteocalcin (OC), which is a later marker of osteoblast differ-
entiation, was down–regulated at day 3 but up-regulated later at day 7 of culture. The initial
down regulation of OC is consistent with an initial proliferative action of Zr that delayed differ-
entiation, followed by an enhancement of differentiation later in the culture period.
We have previously shown that growth of primary human osteoblasts on Zr containing ce-
ramic scaffolds causes as induction of BMP2 expression [8]. We investigated in this study
whether a similar response to soluble Zr ions could be detected. We found that both forms of
Zr used were able to increase the gene expression of BMP2 by HOBs and in addition increases
Figure 7. Localization of phospho-SMAD1/5 in HOBs treated with zirconium solutions. Strong p-SMAD1/5 nucleus localization is detected in the
control (arrows, A,A’) and NaNO3-reated control (E,E’) HOBs. In HOBs treated with ZrO(NO3)2 at 5 µM (B,B’), p-SMAD1/5 has similar localization in the
nucleus as in controls. (C-D) In the HOBs treated with ZrO(NO3)2 at 50 and 500 µM, p-SMAD1/5 localization is strongly detected the nuclei and in cytoplasm
(arrows, C,C’,D’D’). Treated with ZrCl4 at different concentrations of 5, 50 and 500 µM, HOBs show the similar p–SMAD1/5 localization exhibited in the
nucleus and/or cytoplasm, as seen in HOBs treated with ZrO(NO3)2. Scale bar: 50 µm.
doi:10.1371/journal.pone.0113426.g007
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in BMPR1a and BMPR1b were also seen indicating that Zr ions may sensitize osteoblasts to
BMP-mediated effects. Consistent with an activation of BMP2 signaling was the marked in-
crease in phosphorylated SMAD1/5 levels in both the cytoplasm and nucleus of HOBs treated
with Zr ions. The increase in total levels of phosphorylated SMADs observed and the increase
in their nuclear localization indicate the activation of these transcription factors through BMP
ligand interaction with BMP receptors and their potential ability to control osteoblastic gene
expression in response to Zr ions. BMP2 is a potent stimulator of osteoblast differentiation
[30] and its increased expression and the marked increase in phosphorylated SMAD1/5 pro-
vide convincing evidence that BMP2 is a mediator of the osteogenic effects of Zr ions. Suppres-
sion of osteogenic gene expression by noggin, an inhibitor of the BMP signaling pathway, in
HOBs co-treated with Zr ions provides additional evidence that osteogenesis induced by Zr
ions is associated with BMP signaling. The molecular interaction of Zr ions with either BMP
receptors or upstream regulators remains unidentified and we have not investigated Zr ion ef-
fects on other pathways important in osteogensis such as wnt and parathyroid hormone
Figure 8. Noggin suppressed osteogenic gene expression in HOBs treated with ZrCl4. Combined culture of HOBs with ZrCl4 and noggin (500 ng/ml)
suppressed: (A) OPN gene expression at D3 (ZrCl4 at 50 and 500 µM) and D7 (ZrCl4 at 500 µM); (B) BSP gene expression at D7 (ZrCl4 at 500 µM); (C)
Runx2 gene expression at D3 (ZrCl4 at 50 and 500 µM) and at D7 D7 (ZrCl4 at 500 µM); and (D) OC gene expression at D7 (ZrCl4 at 500 µM). *p<0.05,
**p<0.01 vs the same concentration of ZrCl4.
doi:10.1371/journal.pone.0113426.g008
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receptor signaling which may also be modulated by Zr. These questions remain the subject of
ongoing research. The effects of Zr were most pronounced at the concentrations of 50 µM and
500 µM. The relevance of the higher of these concentrations to in vivo findings is currently un-
certain as simple dissolution studies of Zr containing calcium silicate ceramics in simulated
body fluid show relatively low levels of release [6]. Clearly local levels of Zr adjacent to degrad-
ing materials would be much higher than those reported in that study, but the relevance of our
findings to what can be achieved in the local bone environment remains to be confirmed.
Two sources of Zr ions were used, ZrO(NO3)2 and ZrCl4. ZrO(NO3)2 is the form we used in
preparation of Zr containing ceramics by the sol-gel method [7], and ZrCl4 represents the sim-
plest available soluble source of Zr ions. Both of these forms had similar overall effects on the
various parameters assessed. The addition of NO3 ions had no effect on HOBs indicating that
the effects seen with ZrO(NO3)2 treatment was indeed indicative of a Zr effect. We have not as-
sessed non-soluble forms of Zr in the current study and it is possible that Zr containing partic-
ulate debris could have different actions including inflammatory effects as observed for other
prosthesis materials.
Conclusion
We have identified a novel activity of Zr ions on the differentiation of human osteoblasts. This
finding is of interest given the potential benefits of improving the osteogenic properties of or-
thopaedic implants with a process as simple as incorporating labile Zr-containing materials
into orthopaedic implants from where it could be released to enhance bone ingrowth with re-
sultant improvement of implant stability and longevity.
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